As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

Saria is director of the Johns Hopkins Machine Learning and Healthcare Lab. Bayesian's technology, which received an FDA ...